United Guardian (UG) traded up 0.3 % during a 24 hours period ending at 10:33 AM Central Europe on Wednesday 28th. One United Guardian stock can currently be bought for about USD 6.67 on popular exchanges. Current supply of United Guardian stocks is 4.6 mn. United Guardian has a current market capitalization of USD 30.7 mn and approximately USD 50.7 k worth of United Guardian was traded on exchanges in the last 24 hours. Since last month end, United Guardian has traded -6.06 % down. Simple moving average of last 200 days is at USD 6.95. The highest price of past 52 weeks was recorded at USD 8.45 on 07/27/2026. 52 weeks low was at USD 5.58 on 11/25/2025.

Here is how related stocks have performed in the past 24 hours:

  • Mount Logan Capital (MLCI) traded up 1.26 % and now trades at USD 3.21. Current market capitalisation for Mount Logan Capital is USD 35.5 mn.

  • Star Equity (STRR) traded up 1.11 % and now trades at USD 10. Star Equity has a market capitalisation of USD 36.5 mn.

  • Mind (MIND) traded up 2.28 % and now trades at USD 4.04. Mind has a market capitalisation of USD 36.7 mn.

  • Elutia (ELUT) traded up 0.88 % and now trades at USD 0.8. Current market capitalisation for Elutia is USD 35.6 mn.

  • Exozymes (EXOZ) traded up 1.33 % and now trades at USD 3.8. Exozymes has a market capitalisation of USD 35.4 mn. EXOZYMES INC. filed a Form 4 reporting recent changes in the ownership of its common shares by a senior officer. The filing indicates that on 9 October 2026 the officer acquired approximately 3,900 shares, bringing total holdings to just over 32,000 shares. Three days later, on 12 October 2026, the same officer sold roughly 3,700 shares, reducing the holding to about 28,700 shares. The sales were conducted at a price in the mid‑$5 range, reflecting routine transactions used to satisfy tax withholding obligations related to restricted stock units. Additionally, the officer’s restricted stock units, amounting to nearly 63,000 units, vest over time and convert into common stock at no cost. The filing confirms that the officer holds no direct 10‑percent ownership stake in the company.

About United Guardian

United-Guardian, Inc. is an American company that specializes in conducting research, developing, manufacturing, and marketing a variety of products, including pharmaceuticals, cosmetics, health care items, medical devices, and proprietary industrial products. Additionally, they distribute a range of fine organic chemicals, research chemicals, test solutions, indicators, dyes, and reagents. You can find out more about their products and services on their website, www.u-g.com , and they are listed on the Nasdaq stock exchange.